{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:36:16Z","timestamp":1793284576759,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012394","name":"Robert J Kleberg Jr & Helen C Kleberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002243"],"award-info":[{"award-number":["UL1 TR002243"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ard.2026.07.015","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:20:41Z","timestamp":1787390441000},"page":"2183-2193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8075-1100","authenticated-orcid":false,"given":"Jillian P.","family":"Rhoads","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian N.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Littlejohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera G.","family":"Subash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana K.","family":"Shirey-Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Pulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender","family":"Annapureddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Barnado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Crofford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.07.015_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001133","article-title":"Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus","volume":"6","author":"Elefante","year":"2020","journal-title":"RMD Open."},{"key":"10.1016\/j.ard.2026.07.015_bib0002","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/annrheumdis-2018-214677","article-title":"Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes","volume":"78","author":"Barraclough","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ard.2026.07.015_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6290736","article-title":"Depression-, pain-, and health-related quality of life in patients with systemic lupus erythematosus","volume":"2022","author":"Chalhoub","year":"2022","journal-title":"Int J Rheumatol."},{"key":"10.1016\/j.ard.2026.07.015_bib0004","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semarthrit.2018.02.007","article-title":"What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis","volume":"48","author":"Rayes","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.07.015_bib0005","doi-asserted-by":"crossref","unstructured":"Pedroza-D\u00edaz J, Chavarria TPL, Vahos CHM, Ram\u00edrez DFH, Olivares-Mart\u00ednez E, V\u00e1squez G, et al. Proteomic analysis of cerebrospinal fluid: a search for biomarkers of neuropsychiatric systemic lupus erythematosus. Curr Proteomics. 16:110-8. doi:10.2174\/1570164615666180911125252","DOI":"10.2174\/1570164615666180911125252"},{"key":"10.1016\/j.ard.2026.07.015_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186414","article-title":"Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Asano","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.ard.2026.07.015_bib0007","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BOR.0000000000000682","article-title":"Advances in the diagnosis, pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus","volume":"32","author":"Moore","year":"2020","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ard.2026.07.015_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101981","article-title":"Diffuse neuropsychiatric lupus: clinical evidence, immune-mediated mechanisms, and therapeutic insights","volume":"79","author":"Weissman-Tsukamoto","year":"2025","journal-title":"Semin Immunol."},{"key":"10.1016\/j.ard.2026.07.015_bib0009","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41467-020-15224-w","article-title":"Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory","volume":"11","author":"Chan","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.ard.2026.07.015_bib0010","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.07.015_bib0011","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/rheumatology\/keq408","article-title":"Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus","volume":"50","author":"Gono","year":"2011","journal-title":"Rheumatol Oxf Engl."},{"key":"10.1016\/j.ard.2026.07.015_bib0012","doi-asserted-by":"crossref","first-page":"19854","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ard.2026.07.015_bib0013","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ebiom.2015.05.027","article-title":"Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-Aspartate receptor","volume":"2","author":"Chang","year":"2015","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ard.2026.07.015_bib0014","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1073\/pnas.0510055103","article-title":"Immunity and behavior: antibodies alter emotion","volume":"103","author":"Huerta","year":"2006","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.ard.2026.07.015_bib0015","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2009.64","article-title":"Novel neuroprotective mechanisms of memantine: increase in neurotrophic factor release from astroglia and anti-inflammation by preventing microglial activation","volume":"34","author":"Wu","year":"2009","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol."},{"key":"10.1016\/j.ard.2026.07.015_bib0016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/JCMA.0000000000001252","article-title":"A 2025 update on treatment strategies for the Alzheimer\u2019s disease spectrum","volume":"88","author":"Wu","year":"2025","journal-title":"J Chin Med Assoc."},{"key":"10.1016\/j.ard.2026.07.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.150034","article-title":"Memantine modulates neuroinflammation and motor coordination in a Parkinson\u2019s disease model","volume":"1869","author":"Choi","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.ard.2026.07.015_bib0018","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.semarthrit.2011.02.005","article-title":"Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial","volume":"41","author":"Petri","year":"2011","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.07.015_bib0019","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/0961203310389097","article-title":"The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice","volume":"20","author":"Mosca","year":"2011","journal-title":"Lupus."},{"key":"10.1016\/j.ard.2026.07.015_bib0020","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med."},{"key":"10.1016\/j.ard.2026.07.015_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1084\/jem.188.1.29","article-title":"Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition","volume":"188","author":"Putterman","year":"1998","journal-title":"J Exp Med."},{"key":"10.1016\/j.ard.2026.07.015_bib0022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1076\/jcen.20.3.310.823","article-title":"The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity","volume":"20","author":"Randolph","year":"1998","journal-title":"J Clin Exp Neuropsychol."},{"key":"10.1016\/j.ard.2026.07.015_bib0023","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1080\/13854046.2015.1107137","article-title":"The minimum clinically important difference in the Repeatable Battery for the Assessment of Neuropsychological Status","volume":"29","author":"Phillips","year":"2015","journal-title":"Clin Neuropsychol."},{"key":"10.1016\/j.ard.2026.07.015_bib0024","unstructured":"Guy W. National Institute of Mental Health . Psychopharmacology Research Branch., & Early Clinical Drug Evaluation Program. ECDEU assessment manual for psychopharmacology (Rev.). U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs."},{"key":"10.1016\/j.ard.2026.07.015_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000146","article-title":"Real-life assessment of the validity of patient global impression of change in fibromyalgia","volume":"1","author":"Rampakakis","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.ard.2026.07.015_bib0026","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.07.015_bib0027","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3899\/jrheum.141519","article-title":"The use of polysymptomatic distress categories in the evaluation of fibromyalgia (FM) and FM severity","volume":"42","author":"Wolfe","year":"2015","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ard.2026.07.015_bib0028","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J Rheumatol."},{"key":"10.1016\/j.ard.2026.07.015_bib0029","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry."},{"key":"10.1016\/j.ard.2026.07.015_bib0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0961203317713142","article-title":"Depression in systemic lupus erythematosus: gender differences in the performance of the Beck Depression Inventory (BDI), Center for Epidemiologic Studies Depression Scale (CES-D), and Hospital Anxiety and Depression Scale (HADS)","volume":"27","author":"Mac\u00eado","year":"2018","journal-title":"Lupus."},{"key":"10.1016\/j.ard.2026.07.015_bib0031","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand."},{"key":"10.1016\/j.ard.2026.07.015_bib0032","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.semarthrit.2019.03.004","article-title":"Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus","volume":"49","author":"Kwan","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.ard.2026.07.015_bib0033","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00296-017-3819-x","article-title":"Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus","volume":"37","author":"de Almeida Mac\u00eado","year":"2017","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.ard.2026.07.015_bib0034","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ard.2026.07.015_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0961203309346505","article-title":"SLEDAI-2K for a 30-day window","volume":"19","author":"Touma","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2026.07.015_bib0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/nedt.2007.3.2.245","article-title":"Memantine: efficacy and safety in mild-to-severe Alzheimer\u2019s disease","volume":"3","author":"Tampi","year":"2007","journal-title":"Neuropsychiatr Dis Treat."},{"key":"10.1016\/j.ard.2026.07.015_bib0037","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ard.2026.07.015_bib0038","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. Published online 2025. Last updated August 31, 2025. Accessed December 10, 2025. Available from: https:\/\/www.R-project.org\/."},{"key":"10.1016\/j.ard.2026.07.015_bib0039","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1176\/appi.ajp.159.5.838","article-title":"Test-retest stability of the repeatable battery for the assessment of neuropsychological status in schizophrenia","volume":"159","author":"Wilk","year":"2002","journal-title":"Am J Psychiatry."},{"key":"10.1016\/j.ard.2026.07.015_bib0040","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/13803390490918363","article-title":"Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample","volume":"27","author":"Duff","year":"2005","journal-title":"J Clin Exp Neuropsychol."},{"key":"10.1016\/j.ard.2026.07.015_bib0041","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2008.05.024","article-title":"Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder","volume":"105","author":"Chianetta","year":"2008","journal-title":"Schizophr Res."},{"key":"10.1016\/j.ard.2026.07.015_bib0042","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/330604a0","article-title":"Synaptic plasticity. The role of NMDA receptors in learning and memory","volume":"330","author":"Collingridge","year":"1987","journal-title":"Nature."},{"key":"10.1016\/j.ard.2026.07.015_bib0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2466\/pr0.101.1.119-129","article-title":"Relation of the repeatable battery for assessment of neuropsychological status to measures of daily functioning in dementia","volume":"101","author":"Freilich","year":"2007","journal-title":"Psychol Rep."},{"key":"10.1016\/j.ard.2026.07.015_bib0044","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity."},{"key":"10.1016\/j.ard.2026.07.015_bib0045","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12974-024-03288-0","article-title":"NMDA receptor blockade attenuates Japanese encephalitis virus infection-induced microglia activation","volume":"21","author":"Chang","year":"2024","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.ard.2026.07.015_bib0046","doi-asserted-by":"crossref","first-page":"40934","DOI":"10.1021\/acsomega.3c06250","article-title":"Memantine attenuates cognitive and emotional dysfunction in mice with sepsis-associated encephalopathy","volume":"8","author":"Zheng","year":"2023","journal-title":"ACS Omega."},{"key":"10.1016\/j.ard.2026.07.015_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22963-x","article-title":"Glial cell reactivity and oxidative stress prevention in Alzheimer\u2019s disease mice model by an optimized NMDA receptor antagonist","volume":"12","author":"Companys-Alemany","year":"2022","journal-title":"Sci Rep"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600436X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600436X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:07:57Z","timestamp":1793282877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672600436X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S000349672600436X"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.015","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}